Nurses Warn New Federal Policy Could Deepen Workforce Strains and Limit Patient Access

New feedback from nurses shows strong concern that reclassifying advanced nursing degrees, and limiting federal funding—will intensify workforce shortages, increase financial barriers to education, and ultimately affect patient care.

Authored by Charlie Lonardo VP, Digital Client Engagement

Earlier this month, the U.S. Department of Education finalized a policy that removes advanced nursing degrees—MSN and DNP programs—from the federal definition of “professional degrees.” While the change may appear bureaucratic, nurses say its consequences could be far-reaching.

According to the survey we ran with our nursing panel, their reactions were clear: 89% expressed frustration that nursing is not being recognized as a profession, and 83% voiced concern about future workforce shortages. Many linked the decision directly to the pressures already facing the field. “Fewer people will pursue nursing or advanced degrees,” one respondent said.

The financial impact is a central concern. With the removal of federal funding pathways, nurses anticipate reduced access to loans, greater reliance on private lenders, and fewer students entering advanced practice tracks—trends they say will ultimately affect patient care.

The implications extend beyond the nursing profession. Advanced practice nurses play a critical role in delivering complex therapies across oncology, cardiology, neurology, and chronic disease management. As the report notes, shortages could delay treatment, strain infusion centers, and hinder the rollout of therapies that rely on nurse-led education and administration.

Nurses are urging policymakers to reconsider, emphasizing that this decision lands at a time when burnout, vacancies, and rising patient needs already threaten the stability of the healthcare system. For many, the concern is simple: if the pipeline weakens now, patient access will suffer next.

You may also be interested in:

How structured physician communities are driving oncology innovation

As oncology advances, the gap between research and clinical practice continues to widen. While clinical trials provide essential evidence, they cannot fully capture the complexities of real-world care, making direct...
Keep Reading

Can I trust Agentic AI? Validating autonomous analytics for real-world data

This article explores the growing use of agentic AI in healthcare analytics and the critical question of whether these systems can be trusted to generate valid real-world evidence. Agentic AI...
Keep Reading

Impact of Recent Vaccine Recommendation Changes​

In January 2026, vaccine recommendations moved further toward shared clinical decision-making (SCDM), signaling a deliberate shift from routine action to individualized conversation. On paper, it sounds simple: empower patients, respect...
Keep Reading